Avantor, Inc. (NYSE:AVTR – Get Free Report) saw some unusual options trading activity on Monday. Stock traders acquired 26,227 put options on the company. This represents an increase of approximately 384% compared to the typical daily volume of 5,419 put options.
Wall Street Analyst Weigh In
A number of equities research analysts have commented on AVTR shares. Wells Fargo & Company decreased their price target on Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research note on Monday, October 28th. Raymond James reduced their target price on Avantor from $29.00 to $26.00 and set an “outperform” rating on the stock in a report on Tuesday, January 21st. Robert W. Baird reduced their price target on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a report on Monday, October 28th. UBS Group restated a “neutral” rating and issued a $25.00 price objective (down previously from $29.00) on shares of Avantor in a research report on Friday, January 17th. Finally, Barclays increased their price target on shares of Avantor from $25.00 to $26.00 and gave the company an “overweight” rating in a report on Monday. Three analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $27.46.
View Our Latest Analysis on AVTR
Hedge Funds Weigh In On Avantor
Avantor Stock Performance
AVTR opened at $21.89 on Tuesday. The firm’s 50-day moving average price is $21.69 and its 200-day moving average price is $23.46. Avantor has a 52-week low of $19.59 and a 52-week high of $28.00. The company has a market cap of $14.90 billion, a P/E ratio of 47.60, a price-to-earnings-growth ratio of 3.97 and a beta of 1.28. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84.
About Avantor
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Further Reading
- Five stocks we like better than Avantor
- Investing in Construction Stocks
- How to Invest in Small Cap Stocks
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- These Are the Dividend Stocks Insiders Bought in January
- What is Put Option Volume?
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.